Literature DB >> 17389122

Targeting the glutamate system in the treatment of autistic spectrum disorders.

Joseph F Cubells1.   

Abstract

Entities:  

Year:  2007        PMID： 17389122     DOI： 10.1007/s11920-007-0082-y

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN： 1523-3812            Impact factor:   5.285


× No keyword cloud information.
  8 in total

Review 1.  Cognitive remediation and vocational rehabilitation for schizophrenia.

Authors:  Bruce E Wexler; Morris D Bell
Journal:  Schizophr Bull       Date:  2005-08-03       Impact factor: 9.306

Review 2.  Role of risperidone in children with autism spectrum disorder.

Authors:  Benjamin Chavez; Mapy Chavez-Brown; Jose A Rey
Journal:  Ann Pharmacother       Date:  2006-03-07       Impact factor: 3.154

3.  Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors.

Authors:  James S Sutcliffe; Ryan J Delahanty; Harish C Prasad; Jacob L McCauley; Qiao Han; Lan Jiang; Chun Li; Susan E Folstein; Randy D Blakely
Journal:  Am J Hum Genet       Date:  2005-07-01       Impact factor: 11.025

Review 4.  Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability.

Authors:  Alexander Kolevzon; Karen A Mathewson; Eric Hollander
Journal:  J Clin Psychiatry       Date:  2006-03       Impact factor: 4.384

5.  Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.

Authors:  Christopher J McDougle; Lawrence Scahill; Michael G Aman; James T McCracken; Elaine Tierney; Mark Davies; L Eugene Arnold; David J Posey; Andrès Martin; Jaswinder K Ghuman; Bhavik Shah; Shirley Z Chuang; Naomi B Swiezy; Nilda M Gonzalez; Jill Hollway; Kathleen Koenig; James J McGough; Louise Ritz; Benedetto Vitiello
Journal:  Am J Psychiatry       Date:  2005-06       Impact factor: 18.112

6.  The Vineland Adaptive Behavior Scales: supplementary norms for individuals with autism.

Authors:  A S Carter; F R Volkmar; S S Sparrow; J J Wang; C Lord; G Dawson; E Fombonne; K Loveland; G Mesibov; E Schopler
Journal:  J Autism Dev Disord       Date:  1998-08

Review 7.  The use of selective serotonin reuptake inhibitors in autism and related disorders.

Authors:  David J Posey; Craig A Erickson; Kimberly A Stigler; Christopher J McDougle
Journal:  J Child Adolesc Psychopharmacol       Date:  2006 Feb-Apr       Impact factor: 2.576

8.  A genetic variant that disrupts MET transcription is associated with autism.

Authors:  Daniel B Campbell; James S Sutcliffe; Philip J Ebert; Roberto Militerni; Carmela Bravaccio; Simona Trillo; Maurizio Elia; Cindy Schneider; Raun Melmed; Roberto Sacco; Antonio M Persico; Pat Levitt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-19       Impact factor: 11.205
  8 in total
  1 in total

Review 1.  Stem cell therapy for autism.

Authors:  Thomas E Ichim; Fabio Solano; Eduardo Glenn; Frank Morales; Leonard Smith; George Zabrecky; Neil H Riordan
Journal:  J Transl Med       Date:  2007-06-27       Impact factor: 5.531
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.